Precision Optics Reports Fourth Quarter and Fiscal Year 2026 Financial Results

PRECISION OPTICS CORPORATION, INC. (POCI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 PRECISION OPTICS CORPORATION 550 King Street, Bldg. A, Suite 100 Littleton, MA 01460 978 / 630-1800 NEWS RELEASE POC26-0012 FOR IMMEDIATE RELEASE Monday, September 28, 2026 Precision Optics Reports Fourth Quarter and Fiscal Year 2026 Financial Results Conference Call

Event · Earnings
Also in this documentGuidance · initiate · $30M–$33M

Facts are quoted from the filing text and checked against it.

Original reporting
Published Sep 28, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 8:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$POCI
Neutral
medium confidence
Mentioned
$POCI
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$POCINeutralMed
01

Why it matters

The FY 2027 revenue range of $30‑$33 million mirrors FY 2026, signaling a short‑term demand pause that may weigh on the stock.

02

Market read

The filing offers the first public view of FY 2026 performance and FY 2027 guidance, a primary source for investors in this micro‑cap.

03

What to watch

Potential upside from new defense contracts and the upcoming single‑use ophthalmic program could lift revenue later in FY 2027.

Relevance 7/10Novelty 7/10Timing: today, after the 8‑K filing

Background

Precision Optics Corp. (NASDAQ: POCI) designs advanced optical instruments for medical and defense/aerospace markets. The 8‑K filing reports FY 2026 results and FY 2027 outlook.

Company-level read

Ticker impact

$POCINeutralMedium confidence
Context

Precision Optics disclosed FY 2026 results and FY 2027 revenue guidance in its 8‑K filing, providing fresh financial numbers and outlook.

Expected impact

likely modest pressure as the flat FY 2027 revenue range signals limited growth momentum

Evidence & confidence

The company posted record FY 2026 revenue but guided FY 2027 revenue to be similar, indicating a pause in demand; investors may view this as a neutral to slightly negative catalyst.

Market effects

The guidance may temper expectations for the medical‑device optics niche and defense/aerospace optics suppliers.

Limited to U.S. small‑cap investors focused on niche optical equipment.

Minimal, as the company is a micro‑cap with niche exposure.

Counterpoint

The flat guidance could be a buying opportunity if the market overreacts to the pause in satellite demand.

Key entities

  • Joe Forkey

    Provided commentary on FY 2026 performance and FY 2027 outlook.

  • Peter Thier

    New executive appointment mentioned in the release.

Related articles

$POCIMed

Precision Optics Reports First Quarter Fiscal 2027 Financial Results

PRECISION OPTICS CORPORATION, INC. (POCI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 PRECISION OPTICS CORPORATION 550 King Street, Bldg. A, Suite 100 Littleton, MA 01460 978 / 630-1800 NEWS RELEASE POC26-XXXX FOR IMMEDIATE RELEASE Monday, November 16, 2026 Precision Optics Reports First Quarter Fiscal 2027 Financial Results Conference Call Scheduled

$NIUMed

Niu Tech (NIU) Q3 2026 Earnings Call Transcript

Niu Tech (NIU) reported Q3 2026 earnings, with total sales volume up 15.4% YoY to 534,057 units. Revenue was RMB 1.71 billion, up 1.2% YoY. China sales grew 8.6% YoY, while international sales surged 226%. Gross margin expanded to 18.0%. The company highlighted strong growth in electric motorcycles, which accounted for 56% of China sales, and strategic product launches.